Lysyllysine trihydrochloride (L-Lysyl-L-lysine trihydrochloride) is an orally active PepT1 substrate. Lysyllysine trihydrochloride enhances whole-body protein synthesis, improves intestinal structure, alleviates intestinal mucosal inflammation, and exhibits higher lysine bioavailability in neonatal piglets with PN-induced intestinal atrophy. Lysyllysine trihydrochloride inhibits the growth of axenic cyanobacterial strains and induces their cell lysis . Lysyllysine trihydrochloride can be used in studies related to intestinal atrophy and metabolism.
Products | Products > Peptides | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Digestive System Disease | Products > Signaling Pathways > Others | Products > Research Areas > Metabolic Disease | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Amino Acid Derivatives
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.